|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
ELV043875076 |
| 003 |
DE-627 |
| 005 |
20230624105359.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
181113s2018 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.earlhumdev.2018.06.009
|2 doi
|
| 028 |
5 |
2 |
|a GBV00000000000342.pica
|
| 035 |
|
|
|a (DE-627)ELV043875076
|
| 035 |
|
|
|a (ELSEVIER)S0378-3782(18)30212-3
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 084 |
|
|
|a 44.45
|2 bkl
|
| 100 |
1 |
|
|a Seale, Josephine V.
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Does antibiotic choice for the treatment of suspected late-onset sepsis in premature infants determine the risk of developing necrotising enterocolitis? A systematic review
|
| 264 |
|
1 |
|c 2018
|
| 300 |
|
|
|a 5
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 520 |
|
|
|a Necrotising enterocolitis (NEC) is a significant cause of infant morbidity and mortality, disproportionately affecting those of extreme prematurity and/or very low birth weight. A number of risk factors have been identified, including an association between the use of antibiotics, and the subsequent development of NEC.
|
| 700 |
1 |
|
|a Hutchinson, Richard A.
|4 oth
|
| 700 |
1 |
|
|a Fleming, Paul F.
|4 oth
|
| 700 |
1 |
|
|a Sinha, Ajay
|4 oth
|
| 700 |
1 |
|
|a Kempley, Stephen T.
|4 oth
|
| 700 |
1 |
|
|a Husain, Shahid M.
|4 oth
|
| 700 |
1 |
|
|a Millar, Michael R.
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
| 773 |
1 |
8 |
|g volume:123
|g year:2018
|g pages:6-10
|g extent:5
|
| 856 |
4 |
0 |
|u https://doi.org/10.1016/j.earlhumdev.2018.06.009
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_U
|
| 912 |
|
|
|a GBV_ELV
|
| 912 |
|
|
|a SYSFLAG_U
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a GBV_ILN_130
|
| 912 |
|
|
|a GBV_ILN_350
|
| 936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 123
|j 2018
|h 6-10
|g 5
|